Atlantic Ave Magazine November 2023
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
SIPERSTEIN DERMATOLOGY<br />
Offering New Technology<br />
To Detect Melanoma<br />
BY NICOL JENKINS | PHOTOS BY MELISSA KORMAN<br />
Siperstein Dermatology Group offers a group of<br />
Board-Certified dermatologists, physician assistants,<br />
nurse practitioners, and licensed aestheticians who<br />
specialize in patient-centered dermatologic care.<br />
66 | NOVEMBER <strong>2023</strong> | WWW.ATLANTICAVEMAGAZINE.COM<br />
JENNIFER RICHTER, PA-C PERFORMING DERMAGRAPHIX TOTAL BODY PHOTOGRAPHY<br />
Jennifer Richter, a Board-Certified Physician Assistant<br />
who has been at Siperstein Dermatology<br />
for five years, focuses on helping patients by using<br />
her medical expertise and advanced artificial<br />
intelligence to diagnose skin cancer at its earliest<br />
stages, before it becomes life threatening.<br />
Prior to working at Siperstein Dermatology Group,<br />
Jennifer worked in the Department of Dermatology<br />
at Memorial Sloan Kettering Cancer Center in NYC.<br />
She earned her Physician Assistant Degree and Master<br />
of Science from Cornell University. Jennifer has a<br />
particular expertise in dermoscopy, a non-invasive<br />
technique, which uses a combination of magnification<br />
and light to detect skin cancer early and prevent<br />
unnecessary surgical procedures or biopsies. While<br />
at Memorial Sloan Kettering, she worked alongside<br />
international leaders in the dermatology and dermoscopy<br />
field.<br />
“I joined Siperstein Dermatology Group because I loved how<br />
they prioritize the patient experience, making sure that each patient<br />
is provided with the best care and outcome possible. It is a<br />
place where patients are not just a number. They are truly treated<br />
like family. I immediately knew that people genuinely like to work<br />
there. With a culture that always puts the patient first, I continue<br />
to be amazed at how the practice continues to grow by investing<br />
in the latest technology and providing state-of-the-art procedures<br />
and services to our community,” said Jennifer.<br />
She brings her advanced training and clinical experience working<br />
with patients with dysplastic nevus syndrome, melanoma, basal<br />
cell carcinoma, squamous cell carcinoma, and other complex skin<br />
cancers, in addition to those with a history of radiation therapy and<br />
chemotherapy. She also enjoys engaging in clinical research to keep<br />
current with advances in the field.<br />
Siperstein Dermatology offers DermaGraphix Mole Mapping<br />
with AI Technology, which Jennifer is highly trained in using from<br />
her time at Memorial Sloan Kettering. DermaGraphix mole mapping<br />
and tracking analysis uses a high-resolution camera, advanced<br />
software, and whole-body photography to map a patient’s entire<br />
skin surface, creating a photographic baseline of his/her moles. At<br />
follow up visits, artificial intelligence is then utilized to accurately<br />
identify any change in the size, color and shape of lesions, as well as<br />
document any new lesions.<br />
DermaGraphix is the most innovative mole mapping system<br />
available, and it allows Jen to spot new moles more easily as well<br />
as track changes in patients’ existing moles, which is one of the<br />
possible early signs of melanoma. In addition, this system has an<br />
attached dermatoscope, which allows her to visualize and photograph<br />
individual moles using magnification and polarized light to<br />
better detect subtle changes in these moles and patterns that could<br />
be consistent with melanoma. Siperstein Dermatology Group is the<br />
only private practice in Florida to have DermaGraphix with Artificial<br />
Intelligence Technology, and they offer this option to patients at<br />
both offices in Boynton Beach and Boca Raton.<br />
“In an effort to help all of our patients who are at high or low<br />
COPYRIGHTED